Next Article in Journal
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer
Previous Article in Journal
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
Previous Article in Special Issue
Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 15
Issue 16
10.3390/cancers15164197
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications

by
Xianda Zhao
1,
Timothy Starr
2 and
Subbaya Subramanian
1,2,3,*
1
Department of Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USA
2
Department of Obstetrics, Gynecology and Women’s Health, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA
3
Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Cancers 2023, 15(16), 4197; https://doi.org/10.3390/cancers15164197
Submission received: 17 August 2023 / Accepted: 18 August 2023 / Published: 21 August 2023
(This article belongs to the Special Issue Tumor Immunology and Immunotherapy Resistance)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In recent years, cancer immunotherapy research has made remarkable progress, completely transforming the cancer treatment landscape [...]

Share and Cite

MDPI and ACS Style

Zhao, X.; Starr, T.; Subramanian, S. Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications. Cancers 2023, 15, 4197. https://doi.org/10.3390/cancers15164197

AMA Style

Zhao X, Starr T, Subramanian S. Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications. Cancers. 2023; 15(16):4197. https://doi.org/10.3390/cancers15164197

Chicago/Turabian Style

Zhao, Xianda, Timothy Starr, and Subbaya Subramanian. 2023. "Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications" Cancers 15, no. 16: 4197. https://doi.org/10.3390/cancers15164197

APA Style

Zhao, X., Starr, T., & Subramanian, S. (2023). Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications. Cancers, 15(16), 4197. https://doi.org/10.3390/cancers15164197

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop